Evolent Health (EVH) Amortization of Deferred Charges (2017 - 2026)

Evolent Health has reported Amortization of Deferred Charges for 10 years, with the latest figure at $1.9 million in Q2 2026.

• On a quarterly basis, Amortization of Deferred Charges rose 303.73% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $9.5 million, a 215.93% increase from a year earlier, with the FY2025 full-year figure at $7.8 million, up 120.02% from the prior year.
• Amortization of Deferred Charges was $1.9 million for Q2 2026 at Evolent Health, down from $2.9 million in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $3.0 million in Q4 2025, with the low at $300000.0 in Q2 2022.
• Average Amortization of Deferred Charges over 5 years is $1.0 million, with a median of $759000.0 recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Amortization of Deferred Charges tumbled 88.38% in 2022, then jumped 303.73% in 2026.
• Over 5 years, Amortization of Deferred Charges stood at $540000.0 in 2022, then surged by 66.67% to $900000.0 in 2023, then decreased by 0.33% to $897000.0 in 2024, then jumped by 239.13% to $3.0 million in 2025, then sank by 36.03% to $1.9 million in 2026.
• The last three Amortization of Deferred Charges figures came in at $1.9 million (Q2 2026), $2.9 million (Q1 2026), and $3.0 million (Q4 2025), per Business Quant data.